Overexpressed Wnt-7a acts as a potential antitumor immune modulator and predicts poor prognosis in HNSCC
{{output}}
Immune checkpoint inhibitor (ICI) has become the first-line treatment of advanced head and neck squamous cell carcinoma (HNSCC), which has a relatively poor clinical prognosis and high mortality. However, only a proportion of patients respond well to ICI thera... ...
